The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(2-(piperidin-4-yloxy)phenyl)-2-ureidothiophene-3-carboxamide ID: ALA2425625
PubChem CID: 73350827
Max Phase: Preclinical
Molecular Formula: C17H20N4O3S
Molecular Weight: 360.44
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)Nc1sc(-c2ccccc2OC2CCNCC2)cc1C(N)=O
Standard InChI: InChI=1S/C17H20N4O3S/c18-15(22)12-9-14(25-16(12)21-17(19)23)11-3-1-2-4-13(11)24-10-5-7-20-8-6-10/h1-4,9-10,20H,5-8H2,(H2,18,22)(H3,19,21,23)
Standard InChI Key: BXDIGQDHWUHRAU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
12.5701 -10.7060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5690 -11.5255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2770 -11.9345 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9867 -11.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9839 -10.7024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2752 -10.2971 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6896 -10.2886 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4374 -10.6182 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.9819 -10.0088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5706 -9.3026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7720 -9.4756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9016 -8.5526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7140 -8.4640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.4187 -7.8933 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.7950 -10.0912 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1302 -10.8365 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9432 -10.9188 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6523 -11.4994 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2670 -9.4790 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.5552 -9.0776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5490 -8.2615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8413 -7.8601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1353 -8.2724 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1416 -9.0905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8539 -9.4964 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
5 7 1 0
12 13 1 0
12 14 2 0
10 12 1 0
9 15 1 0
15 16 1 0
16 17 2 0
16 18 1 0
6 19 1 0
19 20 1 0
20 21 1 0
20 25 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 360.44Molecular Weight (Monoisotopic): 360.1256AlogP: 2.14#Rotatable Bonds: 5Polar Surface Area: 119.47Molecular Species: BASEHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 6#RO5 Violations (Lipinski): 1CX Acidic pKa: 10.62CX Basic pKa: 9.75CX LogP: 1.13CX LogD: -0.91Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.65Np Likeness Score: -0.49
References 1. Hendrickx R, Johansson JG, Lohmann C, Jenvert RM, Blomgren A, Börjesson L, Gustavsson L.. (2013) Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2., 56 (18): [PMID:23984907 ] [10.1021/jm400966v ]